Syndesi Therapeutics' Series A Round

Syndesi Therapeutics raised a round of funding on February 09, 2018.

Syndesi Therapeutics is developing molecules that uniquely modulate the synaptic vesicle protein SV2A, which plays a central role in synaptic transmission (the communication between neurons in the bra…

Articles about Syndesi Therapeutics' Series A Round: